Research·October 25, 2026 at 12:58 PM EDT·1 source
STAT+: At ESMO, AstraZeneca’s cancer pursuits get a showcase
AZN -0.6%
AZN · last 30 trading days-0.6% since the news
News
What happened
- AstraZeneca’s oncology work received significant attention at ESMO, Europe’s leading cancer conference.
- The company has gained substantial momentum in oncology in recent years.
Why it matters
The conference showcase highlights AstraZeneca’s oncology activity for healthcare professionals tracking cancer research and pharmaceutical competition.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 23China’s rapid human trials draw western drugmakers — and safety concerns
- EarlierYesterdayAmgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
- EarlierYesterday#ESMO26: AstraZeneca eyes Keytruda's Padcev spot; Lilly's ADC takes on Elahere; Nubeqa targets earlier prostate cancer
- Earlier6h#ESMO26: AstraZeneca's Tagrisso-Orpathys combo may extend Tagrisso's life in lung cancer
- First reported by STAT4hSTAT+: At ESMO, AstraZeneca’s cancer pursuits get a showcase
Sources (1)
Related
- 6h · #ESMO26: AstraZeneca's Tagrisso-Orpathys combo may extend Tagrisso's life in lung cancer
- Yesterday · #ESMO26: AstraZeneca eyes Keytruda's Padcev spot; Lilly's ADC takes on Elahere; Nubeqa targets earlier prostate cancer
- Yesterday · Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
- Oct 23 · China’s rapid human trials draw western drugmakers — and safety concerns
- Oct 22 · Roche talks up Phase 3 success rate as it unveils pipeline cuts
- Oct 20 · AstraZeneca Partners With Oracle to Refine Clinical Research With AI
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.